학술논문
Does R-IPI Remain Predictive of Relapse Risk for Patients with DLBCL Achieving a Complete Remission with Frontline Therapy: Landmark Analysis of Two Large Prospective Clinical Trials
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:7908-7909
Subject
Language
ISSN
0006-4971